CONSOLIDATED STATEMENTS OF CASH FLOW (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating Activities
Net income	$ 12,993	$ 12,172
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	5,600	9,600
Depreciation expense	2,730	2,546
Amortization of mortgage servicing rights	933	552
Valuation allowance on mortgage servicing rights	226
Securities amortization, net	2,187	1,103
Stock based compensation expense	344	134
Amortization of purchased intangible assets	900	984
Earnings on cash surrender value of life insurance policies	(567)	(594)
Gain on life insurance benefit		(141)
Securities gains	(535)	(3,654)
Loss on sale and write-down of OREO	213	561
Gain on loans sold	(2,703)	(1,510)
Loans originated for sale	(99,336)	(73,243)
Proceeds from loan sales	107,781	76,076
Change in other assets and liabilities	(398)	2,807
Net cash provided by operating activities	30,368	27,393
Investing Activities
Purchases of securities available for sale	(93,938)	(199,816)
Proceeds from calls, maturities, and payments on securities available for sale	55,739	65,032
Proceeds from sales of securities available for sale	20,886	120,600
Proceeds from life insurance benefit		893
Proceeds from sale of OREO	8,452	9,667
Loan originations and payment, net	(22,277)	41,064
Purchases of premises and equipment	(1,818)	(3,447)
Proceeds from redemption of restricted stock	11	2,191
Net cash provided/(used) by investing activities	(32,945)	36,184
Financing Activities
Net change in deposits	25,196	32,082
Net change in other borrowings	(1,361)	7,627
Repayment of FHLB advances	(5,277)	(10,373)
Proceeds from exercise of stock options	66
Repurchase of preferred stock	(21,324)
Cash dividends on preferred stock	(1,154)	(1,425)
Cash dividends on common stock	(405)	(403)
Net cash provided/(used) by financing activities	(4,259)	27,508
Net change in cash and cash equivalents	(6,836)	91,085
Cash and cash equivalents, beginning of year	109,148	60,123
Cash and cash equivalents, end of period	$ 102,312	$ 151,208